辉瑞公司召回三款降血压药
Pfizer recalls 3 blood pressure medications
Pfizer has issued a recall for three high blood pressure medications, according to the company.
辉瑞公司已经发布了三种降血压药召回通告
Accuretic and two generic drugs distributed by Greenstone -- quinapril and hydrochlorothiazide tablets and quinapril HCl/hydrochlorothiazide tablets -- are subject to the recall.
喹那普利和由绿石公司分销的两种含喹那普利的药物——喹那普利氢氯噻嗪片和盐酸喹那普利氢氯噻嗪片，都属于召回行列。
The medications treat hypertension, which increases the risk for potential dangerous cardiovascular events like strokes.
这些药物治疗高血压病。高血压病会增加潜在心血管事件风险，如中风。
The recall is voluntary, and stems from the tablets containing higher levels of nitrosamines, which pose a cancer risk, although Pfizer said in a news release "there is no immediate risk to patients taking this medication."
本次召回是自愿的。药片中含有较高水平的亚硝胺类物质。尽管辉瑞公司在新闻发布会中说，服用这些药物的患者没有即时风险，但该物质有致癌风险。
Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time," Pfizer said in the news release.
亚硝胺类物质在水和食物中很常见，包括加工与烤制肉类，乳制品和蔬菜。每个人都接触一定水平的亚硝胺。辉瑞公司在新闻发布中讲：如果人们长期摄入超过可接受水平的亚硝胺类，这类杂质会增加致癌风险。
Pfizer recommended that patients taking the medication consult with their doctor about alternative treatment options.
辉瑞公司建议服上述药物的患者，就替代治疗方案咨询医生。
High blood pressure is a growing problem: The number of people over 30 with the condition has doubled over the past 30 years, according to a 2021 study.
根据一项2021年的研究，高血压病是个日益严峻的问题：30岁以上人群患此病的数量在过去三十年中翻了一番。
最后编辑于 2022-10-09 · 浏览 1059
